• to lessen the risk of significant cardiovascular (heart and blood vessel) issues in Grown ups with form 2 diabetes and heart problems In October 2024, Novo Nordisk printed a review on scientific journal Character a couple of novel glucose-delicate insulin NNC2215 that will reduce the c